Opioid Use in Pelvic Fractures: The Impact of Opioid Prescribing Laws in Pennsylvania.
Publication/Presentation Date
7-1-2024
Abstract
Pennsylvania's Prescription Drug Monitoring Program (PDMP) was established in 2016, but its impact on opioid use for pelvic fractures is understudied. We compared opioid use in 277 pelvic fracture cases between two periods: 2015-2017 (T1) and 2018-2020 (T2). Outcomes included daily inpatient morphine milligram equivalents (MME), long-term opioid use (LOU) 60-90 days post-discharge, and intermediate-term opioid use (IOU) 30-60 days post-discharge. T1 and T2 had comparable baseline characteristics. T2 was associated with a decrease in average daily inpatient MME (58.6 vs 78.5,
Volume
90
Issue
7
First Page
1937
Last Page
1939
ISSN
1555-9823
Published In/Presented At
Villa, N. A. E., Shum, K., Atkinson, A., Ong, A., Muller, A., & Espiridion, E. (2024). Opioid Use in Pelvic Fractures: The Impact of Opioid Prescribing Laws in Pennsylvania. The American surgeon, 90(7), 1937–1939. https://doi.org/10.1177/00031348241241644
Disciplines
Medicine and Health Sciences
PubMedID
38516756
Department(s)
Fellows and Residents
Document Type
Article
